Equity Research firms currently have a positive stance on shares of Adeptus Health Inc. (NYSE:ADPT). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.40. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $69.71 on a short term basis.
At the time of writing, the stock was trading at $39.49. This represents a change from the opening price of -0.28%. In terms of performance, year to date, the stock is -27.13%. The monthly stock performance comes in at 11.29%. For the quarter, shares are performing at -30.37%. Weekly performance analysis shows the equity at -3.96%.
In taking a look at technical levels, shares are trading -6.18% away from the 50 day simple moving average and -24.15% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -56.47% away from it’s 52- week high and 11.77% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Adeptus Health Inc.’s RSI stands at 43.03. In looking at volatility levels, the shares saw weekly volatility of 4.23% and 4.13% over the past month.